Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
about
Pharmacological Targeting of the Hepcidin/Ferroportin AxisTargeting iron metabolism in drug discovery and deliveryIron and inflammation - the gut reaction.Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver.Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.The mutual control of iron and erythropoiesis.Regulation of the Iron Homeostatic Hormone Hepcidin.A Red Carpet for Iron Metabolism.Systemic iron homeostasis and erythropoiesis.Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.Erythroferrone and matriptase-2 independently regulate hepcidin expression.Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.Hepcidin: a real-time biomarker of iron need.Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.Evaluation of gene expression levels for cytokines in ocular toxoplasmosis.Emerging Therapies.Smad7 deficiency decreases iron and haemoglobin through hepcidin up-regulation by multilayer compensatory mechanisms.Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
P2860
Q26738350-541809A3-7CBB-46CD-AE09-927F76C803DAQ33757232-D4EB42C8-1B2E-48D2-8A63-009B4BA68257Q34548797-679AA388-2199-4256-94A3-49C956E847F8Q37066050-D64E6CC4-EBDF-46C9-A8B6-9370FF29A8B3Q38706268-D8CD442E-1342-4975-82E7-0E270E72D795Q38830409-2C2232DE-21BF-46B6-8690-E8624CEFB49EQ39092558-07BE9D57-4CEA-4217-A004-A1B55F20DD83Q39106718-45BD94BD-126C-4C27-8A46-5D7FB1A98E18Q39226004-C3734154-D271-4917-96BD-B50E985ED66CQ41594444-9CAFF50C-D48E-4E87-9497-A8C0FABA6D9CQ46320490-B4947395-17C1-471E-9F0D-93F645369B79Q47101427-00703BF3-2121-4A58-9933-313904CA4908Q47732977-91B9FE57-3DD0-440C-9124-B7382D279BA5Q47781819-792707BA-F246-4675-9BE4-1EE9DEA8C287Q47912179-1F43EA3B-DA7F-4C9D-B66F-78BE6989A5BBQ49837060-91B7F49D-0AF7-4BC1-8C9D-AB995F7CA1E0Q54249047-57BA0021-A9C5-4543-8112-6DAEC2E6151AQ58793890-28FF3857-DC50-44BA-9F4A-C379879309E6
P2860
Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Limiting hepatic Bmp-Smad sign ...... hepcidin suppression in mice.
@en
type
label
Limiting hepatic Bmp-Smad sign ...... hepcidin suppression in mice.
@en
prefLabel
Limiting hepatic Bmp-Smad sign ...... hepcidin suppression in mice.
@en
P2093
P2860
P50
P1433
P1476
Limiting hepatic Bmp-Smad sign ...... hepcidin suppression in mice.
@en
P2093
Aude Rubio
Aurélie Gineste
Chloé Latour
Clara Camaschella
Céline Besson-Fournier
Delphine Meynard
Herbert Y Lin
Hélène Coppin
Irene Artuso
Marie-Paule Roth
P2860
P304
P356
10.1182/BLOOD-2015-11-681494
P407
P577
2016-01-11T00:00:00Z